The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis

By F. Martinez, S. Safrin, D. Weycker, K. Starko, W. Bradford, T. King, K. Flaherty, David A. Schwartz, P. Noble, G. Raghu and 1 more. Annals of Internal Medicine, 2005

596 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/ceb6b19ca82fc60b2804805892adca623533fae3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. H. Collard
2. B. Ley
3. T. King

Citations in the corpus

• Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression (2010, background): “The instability inherent in the presence of a mechanobiological profibrotic feedback loop could help to explain the variable course of the disease and rapid declines in lung function seen in exacerbations of lung fibrosis (Martinez et al., 2005; Collard et al., 2007).”
• Clinical course and prediction of survival in idiopathic pulmonary fibrosis. (2011, background): “However, a substantial minority of patients experienced acute deterioration leading to death (sudden worsening of less than 4 wk duration) (Figure 3) (3, 4, 26, 29, 43).”
• Hyaluronan as an Immune Regulator in Human Diseases (2011, unknown): “For many patients with IPF, lung transplantation is the only available and effective treatment (271).”
• Interstitial lung disease guideline (2008, unknown): “Известно, что у некоторых больных ИЛФ протекает атипично: острые ухудшения состояния чередуются с периодами относительной стабильности [709, 710].”